189 related articles for article (PubMed ID: 26132564)
21. Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids.
Hou W; Luo Z; Zhang G; Cao D; Li D; Ruan H; Ruan BH; Su L; Xu H
Eur J Med Chem; 2017 Sep; 138():1042-1052. PubMed ID: 28759877
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antitumor activities of novel α-aminophosphonate derivatives containing an alizarin moiety.
Ye MY; Yao GY; Pan YM; Liao ZX; Zhang Y; Wang HS
Eur J Med Chem; 2014 Aug; 83():116-28. PubMed ID: 24953029
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of 1,2,4-triazole-linked urea/thiourea conjugates as cytotoxic and apoptosis inducing agents.
Tokala R; Bale S; Janrao IP; Vennela A; Kumar NP; Senwar KR; Godugu C; Shankaraiah N
Bioorg Med Chem Lett; 2018 Jun; 28(10):1919-1924. PubMed ID: 29657100
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and antiproliferative evaluation of novel dehydroabietic acid-1,2,3-triazole-oxazolidinone hybrids.
Wu Y; Huang L; Ma X; Zhou X; Li Q; Li F
RSC Med Chem; 2024 Feb; 15(2):561-571. PubMed ID: 38389893
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of betulonic acid derivatives as antitumor agents.
Yang SJ; Liu MC; Zhao Q; Hu DY; Xue W; Yang S
Eur J Med Chem; 2015; 96():58-65. PubMed ID: 25874331
[TBL] [Abstract][Full Text] [Related]
26. Identification of a diverse synthetic abietane diterpenoid library for anticancer activity.
Xu H; Liu L; Fan X; Zhang G; Li Y; Jiang B
Bioorg Med Chem Lett; 2017 Feb; 27(3):505-510. PubMed ID: 28011223
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
Luo H; Yang S; Cai Y; Peng Z; Liu T
Eur J Med Chem; 2014 Sep; 84():746-52. PubMed ID: 25064351
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and Antiproliferative Evaluation of Novel Hybrids of Dehydroabietic Acid Bearing 1,2,3-Triazole Moiety.
Li FY; Huang L; Li Q; Wang X; Ma XL; Jiang CN; Zhou XQ; Duan WG; Lei FH
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752282
[TBL] [Abstract][Full Text] [Related]
29. Halogenated flavanones as potential apoptosis-inducing agents: synthesis and biological activity evaluation.
Safavi M; Esmati N; Ardestani SK; Emami S; Ajdari S; Davoodi J; Shafiee A; Foroumadi A
Eur J Med Chem; 2012 Dec; 58():573-80. PubMed ID: 23174316
[TBL] [Abstract][Full Text] [Related]
30. Novel rotundic acid derivatives: synthesis, structural characterization and in vitro antitumor activity.
Chen Y; He YF; Nan ML; Sun WY; Hu J; Cui A; Li F; Wang F
Int J Mol Med; 2013 Feb; 31(2):353-60. PubMed ID: 23233042
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and antitumor evaluation of a new series of N-substituted-thiourea derivatives.
Li J; Tan JZ; Chen LL; Zhang J; Shen X; Mei CL; Fu LL; Lin LP; Ding J; Xiong B; Xiong XS; Liu H; Luo XM; Jiang HL
Acta Pharmacol Sin; 2006 Sep; 27(9):1259-71. PubMed ID: 16923349
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro study of pseudo-peptide thioureas containing α-aminophosphonate moiety as potential antitumor agents.
Liu JZ; Song BA; Fan HT; Bhadury PS; Wan WT; Yang S; Xu W; Wu J; Jin LH; Wei X; Hu DY; Zeng S
Eur J Med Chem; 2010 Nov; 45(11):5108-12. PubMed ID: 20817326
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and cytotoxicity of cell death mechanism of rotundic acid derivatives.
He YF; Nan ML; Sun JM; Meng ZJ; Li W; Zhang M
Bioorg Med Chem Lett; 2013 May; 23(9):2543-7. PubMed ID: 23558236
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of dehydroabietic acid derivatives.
González MA; Pérez-Guaita D; Correa-Royero J; Zapata B; Agudelo L; Mesa-Arango A; Betancur-Galvis L
Eur J Med Chem; 2010 Feb; 45(2):811-6. PubMed ID: 19892441
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, molecular modeling, and biological evaluation of novel chiral thiosemicarbazone derivatives as potent anticancer agents.
Taşdemir D; Karaküçük-İyidoğan A; Ulaşli M; Taşkin-Tok T; Oruç-Emre EE; Bayram H
Chirality; 2015 Feb; 27(2):177-88. PubMed ID: 25399965
[TBL] [Abstract][Full Text] [Related]
36. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents.
Yang J; Liu Y; Xue C; Yu W; Zhang J; Qiao C
Eur J Med Chem; 2014 Oct; 86():235-41. PubMed ID: 25164762
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Eur J Med Chem; 2011 Nov; 46(11):5356-69. PubMed ID: 21959232
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro antitumor activities of lupeol dicarboxylic acid monoester derivatives.
Li W; Hao J; Xiao Y
Arch Pharm Res; 2013 Dec; 36(12):1447-53. PubMed ID: 23700293
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of derivatives of 4-deoxypodophyllotoxin as antitumor agents.
Jin Y; Liu J; Huang WT; Chen SW; Hui L
Eur J Med Chem; 2011 Sep; 46(9):4056-61. PubMed ID: 21733601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
